Table 1 Group comparison of characteristics (Table 1)
| Â | Gram positive pathogen (n = 11) | Gram Negative pathogen (n = 35) | p value |
|---|---|---|---|
Age | 59 (34, 72) | 64(22, 85) | 0.138 |
Gender(Male/Female) | 9/2 | 26/9 | 1.000 |
Involved region | Â | Â | Â |
   Upper extremity | 5 (45.5) | 10 (28.6) | 0.462 |
   Lower extremity | 6 (54.5) | 25 (71.4) |  |
TiOA(day) | 7.18 (2, 14) | 2.43 (0.5, 14)* | < 0.001 |
TiOS(hour) | 25.64 (2, 72) | 11.74 (1, 72)* | 0.046 |
Immunocompromised(DM, liver dysfunction, Chronic renal failure, Malignancy) | 5 (45.5) | 29 (82.8)* | 0.022 |
Comorbidity | Â | Â | Â |
   DM | 5 (45.5) | 13 (37.1) | 0.728 |
   Gout | 5 (45.5) | 2 (5.7)* | 0.005 |
   Chronic renal failure (> 1.6 mg/dL) | 2 (18.2) | 7 (20) | 1.000 |
Chronic Liver dysfunction | 1 (9.1) | 18 (51.4)* | 0.016 |
   HBV | 0 (0) | 11 (31.4)* | 0.044 |
   HCV | 1 (9.1) | 11 (31.4) | 0.241 |
   HBV or HCV | 1 (9.1) | 17 (48.6)* | 0.032 |
   Liver cirrhosis | 0 | 8 (22.9) | 0.619 |
ICU stay(patient number) | 4 (36.4) | 26 (74.3)* | 0.032 |
Post-operative mechanical ventilation (patient number) | 4 (36.4) | 24 (68.6) | 0.080 |
APACHE II score | 12.9 (3, 21) | 18.9 (2, 34)* | 0.015 |
ICU stay (day) | 2 (0, 7) | 4.3 (0, 16) | 0.077 |
Hospital stay (day) | 35.7 (15, 70) | 35.8 (13, 87) | 0.800 |
Amputation | 0 | 5 (10.9) | 0.317 |
STSG | 5 (45.5) | 21 (60) | 0.494 |
Free flap transfer | 1 (9.1) | 7 (20) | 0.658 |
Mortality | 1(9.1) | 6(17.1) | 1.000 |